Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 24, 2026

Back to today

Tower Semiconductor Deep Dive

Tower Semiconductor’s low-loss photonics chips halve lasers in 1.6T optical modules, supporting a $680 million annualized photonics run rate and customer wafer prepayments through 2027.

TSEM $22B
CV's Substack 10 clicks

From X

@ACapitalLP 3 clicks

A Capital on X

Still working through them, but I think you have to underwrite each one separately. Counterparty credit, remaining financing needs, construction execution, power certainty (especially Texas/ERCOT), and how much pipeline value is already priced in. $CORZ and $CIFR screen as the most dislocated on my framework, but the discounts aren’t necessarily irrational. The exercise is figuring out which risks are already more than priced in…
@ACapitalLP 2 clicks

A Capital on X

𝙋𝙤𝙬𝙚𝙧𝙚𝙙 𝙎𝙝𝙚𝙡𝙡 𝙋𝙧𝙤𝙫𝙞𝙙𝙚𝙧𝙨 (𝙋𝙎𝙋) 𝙑𝙖𝙡𝙪𝙖𝙩𝙞𝙤𝙣 𝙁𝙧𝙖𝙢𝙚𝙬𝙤𝙧𝙠 $APLD $CIFR $WULF $CORZ $HUT I think people forget that these are real estate companies. That’s why I like “Powered Shell Providers” vs. “AI/HPC” as a descriptor (h/t Morgan Stanley). They secure land and power, develop data centers and lease the infrastructure under long-term contracts. At the end of the day, they have two things of value: (1) an existing portfolio of contracted assets and (2) a pipeline of future developments. That’s it… The valuation exercise is pretty straightforward. Take the stabilized NOI from contracted leases, apply an appropriate cap rate, subtract remaining construction costs and debt, and add back cash and other assets. That’s your theoretical “equity floor.” Then take the uncontracted pipeline, separate it into ~three? buckets based on development readiness, assign each bucket an equity value per MW and a probability of commercialization, and add the risk-adjusted value to the contracted business. Note: You can also reverse-engineer the current share price to see how much the market is implicitly paying for the pipeline. So what’s the worst-case scenario? Why should $CRWV neocloud debt blowing out matter to a landlord with a 15-year lease? There are legitimate risks. Some projects aren’t fully financed, some tenants are more creditworthy than others, and higher financing costs can impact both the ability to complete existing developments and the value of contracted cash flows. Given the leverage involved, even a modest increase in cap rates can have an enormous impact on residual equity value. That’s why the contracted floor isn’t necessarily a hard floor… (but this is true for every stabilized real estate company) But I think the market is conflating two very different things: the value of infrastructure already contracted to a creditworthy tenant and the value of speculative capacity that still needs to be financed, built and leased. Neoclouds own GPUs, rent out compute and face enormous hardware depreciation and recurring capital requirements. PSPs are fundamentally landlords. A deterioration in neocloud financing conditions absolutely matters for tenant credit and future development, but it doesn’t automatically mean that every existing lease is worth less...

Investor Letters

All letters

Deep Dive: $ASML

ASML’s €230 million EUV machines underpin advanced AI chip production, with demand booked through 2028 after nearly $9 billion and two…

ASML $610B
Rebound Capital 9 clicks

Margin Call

Petrobras’s Morpho-1 well revived hopes that Brazil’s Equatorial Margin can become a major new oil frontier after hydrocarbons were…

PBR $81B
Doomberg 12 clicks

Our Views on CoreWeave

CoreWeave's financial statements point to a business model familiar to the authors after a closer review of the AI infrastructure company.

CRWV $34B
WHAT ARE WE DOING? “Contrarians At The Gate” 13 clicks
SYK · long

Stryker CORP

Stryker (SYK) trades near a 52-week low after a late-Q1 cyberattack disrupted revenue and earnings, framing a long-term compounder…

SYK $116B
Value Investors Club 4 clicks

ALTO- ALTO ingredients

ALTO Ingredients trades near half of book value after plant upgrades and lower corn prices set up a recovery in crush margins and cash flow.

ALTO $289M
Sylence Capital 1 click

Notes and Updates

ECIP recipient banks could repurchase Treasury preferred shares at steep discounts, potentially lifting book value, while Hawaiian Electric…

HE $1.5BUBAB $189M
Exploring with Alluvial Capital

Mereo Biopharma

Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.

MREO $47M
Raging Bull Investments

Revisiting An Old Idea

Instil Bio leased its 128,000-square-foot Tarzana life-sciences building to AstraZeneca for 15 years at $7.52 million annual rent,…

TIL $40M
Raging Bull Investments

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 264

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.